{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:37:49Z","timestamp":1782286669951,"version":"3.54.5"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is relatively rare in children. This article aimed to analyze clinical and renal histology findings and different responses to induction treatment associated with the long-term renal outcomes in children with AAV in a single center.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All pediatric patients with AAV admitted to Tongji Hospital from January 2002 to January 2021 were included in the study. The demographic, clinical, pathological, laboratory, and treatment data and outcomes were collected and analyzed to identify predictors associated with response to induction treatment and progression to end-stage renal disease (ESRD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 48 children with AAV were included in this cohort; 81.25% of them were women, and 91.7% were microscopic polyangiitis (MPA). Kidney involvement was found in 45 patients (93.75%). The most common histopathological subtype was crescentic form in this cohort according to Berden\u2019s classification. In total, 34 patients (70.8%) showed eGFR &amp;lt;60\u00a0ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup> at the time of diagnosis. Complete and partial remission was achieved in 8 patients (16.7%) and 19 patients (39.6%), respectively, following 6-month induction treatment. Half of the patients eventually progressed to ESRD at a mean time of (13.04\u00a0\u00b1\u00a015.83)\u00a0months after diagnosis. The independent predictors of nonremission following induction treatment and progression to ESRD were baseline eGFR &amp;lt;60\u00a0ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup> and hypertension at diagnosis. Renal survival significantly decreased over time in patients with renal sclerotic subtypes or those with nonremission following induction treatment by Kaplan\u2013Meier curve estimation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study demonstrates that women, MPA, and crescentic subtypes are predominant in pediatric AAV in China. Initial renal failure (eGFR &amp;lt;60\u00a0ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>), hypertension, sclerotic pathological subtype, and nonremission following induction treatment are predictive of long-term renal outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.857813","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:01:26Z","timestamp":1649934086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical and Renal Histology Findings and Different Responses to Induction Treatment Affecting the Long-Term Renal Outcomes of Children With ANCA-Associated Vasculitis: a Single-Center Cohort Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luowen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liru","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13052-017-0364-x","article-title":"ANCA-Associated Vasculitis in Childhood: Recent Advances","volume":"43","author":"Calatroni","year":"2017","journal-title":"Ital J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-Associated Vasculitis: Core Curriculum 2020","volume":"75","author":"Geetha","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01210214","article-title":"The New Histopathologic Classification of ANCA-Associated GN and its Association With Renal Outcomes in Childhood","volume":"9","author":"Noone","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv016","article-title":"Favourable Renal Survival in Paediatric Microscopic Polyangiitis: Efficacy of a Novel Treatment Algorithm","volume":"30","author":"Basu","year":"2015","journal-title":"Nephrol Dialysis Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2970-9","article-title":"Pauci-Immune Glomerulonephritis in Children: A Clinicopathologic Study of 21 Patients","volume":"30","author":"Khalighi","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-016-3490-6","article-title":"Clinical Presentation and Outcome of Pediatric ANCA-Associated Glomerulonephritis","volume":"32","author":"Kouri","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4162-5","article-title":"Clinical and Histopathological Prognostic Factors Affecting the Renal Outcomes in Childhood ANCA-Associated Vasculitis","volume":"34","author":"Ozcelik","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.19181220","article-title":"Prognostic Factors and Long-Term Outcome With ANCA-Associated Kidney Vasculitis in Childhood","volume":"16","author":"Calatroni","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.656307","article-title":"Clinicopathological Analysis of 34 Cases of Primary Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Chinese Children","volume":"9","author":"Wu","year":"2021","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv011","article-title":"Clinical Characteristics and Outcomes of Childhood-Onset ANCA-Associated Vasculitis: A French Nationwide Study","author":"Sacri","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR-Recommendations-Fpr-The-Management-Of-Primary-Small-And-Medium-Vessel-Vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202111","article-title":"Disease Activity Assessment in Childhood Vasculitis: Development and Preliminary Validation of the Paediatric Vasculitis Activity Score (PVAS)","volume":"72","author":"Dolezalova","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic Classification of ANCA-Associated Glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"102495","DOI":"10.1016\/j.autrev.2020.102495","article-title":"Clinical Associations of Renal Involvement in ANCA-Associated Vasculitis","volume":"19","author":"Kronbichler","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/art.40112","article-title":"Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"69","author":"Morishita","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.39729","article-title":"Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study","volume":"68","author":"Cabral","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40620-017-0412-z","article-title":"ANCA-Associated Vasculitis With Renal Involvement","volume":"31","author":"Binda","year":"2018","journal-title":"J Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.11817\/j.issn.1672-7347.2020.190436","article-title":"Clinical Characteristics and Prognosis in 269 Patients With Antineutrophil Cytoplasimc Antibody Associated Vasculitis","volume":"45","author":"Wu","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B20","article-title":"Clinical and Prognostic Features of Korean Patients With MPO-ANCA, PR3-ANCA, and ANCA-Negative Vascylitis","volume":"35","author":"Yoo","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker205","article-title":"Comparison of the Epidemiology of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Between Japan and the U.K","volume":"50","author":"Fujimoto","year":"2011","journal-title":"Rheumatol (Oxf)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137778","article-title":"Long-Term Patient Survival in ANCA-Associated Vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.08.025","article-title":"Histopathologic and Clinical Predictors of Kidney Outcomes in ANCA-Associated Vasculitis","volume":"63","author":"Ford","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.07.004","article-title":"The BVAS is an Independent Predictor of Cardiovascular Events and Cardiovascular Disease-Related Mortality in Patients With ANCA-Associated Vasculitis: A Study of 504 Cases in a Single Chinese Center","volume":"47","author":"Bai","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"B25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3349\/ymj.2018.59.3.397","article-title":"Delta Neutrophil Index Is Associated With Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis","volume":"59","author":"Yoo","year":"2018","journal-title":"Yonsei Med J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1\u201310","DOI":"10.1155\/2020\/3530768","article-title":"Clinical Characteristics of Peripheral Neuropathy in Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Single-Center Study in China","author":"Zhang","year":"2020","journal-title":"J Immunol Res 2020"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005080870","article-title":"Clinical and Histologic Determinants of Renal Outcome in ANCA-Associated Vasculitis: A Prospective Analysis of 100 Patients With Severe Renal Involvement","volume":"17","author":"de Lind van Wijngaarden","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160866","article-title":"Histopathological Classification and Renal Outcome in Patients With Antineutrophil Cytoplasmic Antibodies-Associated Renal Vasculitis: A Study of 186 Patients and Metaanalysis","volume":"44","author":"Chen","year":"2017","journal-title":"J Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000494840","article-title":"Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis","volume":"48","author":"Menez","year":"2018","journal-title":"Am J Nephrol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00605.x","article-title":"Determinants of Outcome in ANCA-Associated Glomerulonephritis:A Prospective Clinico-Histopathological Analysis of 96 Patients","volume":"62","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab Versus Cyclophosphamide in ANCA-Associated Renal Vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.857813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:01:31Z","timestamp":1649934091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.857813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2022.857813"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.857813","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"article-number":"857813"}}